MASTER RESEARCH AND COLLABORATION AGREEMENT by and among ONCOMED PHARMACEUTICALS, INC. and CELGENE CORPORATION and CELGENE ALPINE INVESTMENT COMPANY II, LLC Dated as of December 2, 2013Master Research and Collaboration Agreement • March 18th, 2014 • OncoMed Pharmaceuticals Inc • Pharmaceutical preparations • New York
This MASTER RESEARCH AND COLLABORATION AGREEMENT (this “Agreement”) is entered into and made effective as of December 2, 2013 (the “Effective Date”) by and among OncoMed Pharmaceuticals, Inc., a Delaware corporation (“OncoMed”), and Celgene Corporation, a Delaware corporation (“Celgene Corp.”), with respect to all rights and obligations under this Agreement in the United States (subject to Section 12.14), and Celgene Alpine Investment Company II, LLC (“Celgene Alpine”), a Delaware limited liability company, with respect to all rights and obligations under this Agreement outside of the United States (subject to Section 12.14) (Celgene Alpine and Celgene Corp., together, “Celgene”). Celgene and OncoMed are each referred to herein by name or as a “Party”, or, collectively, as the “Parties.”
